| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.5 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.5 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |